SNCA and Parkinson disease: The present results are consistent with previous findings showing an elevation of oligomeric α-synuclein in plasma, CSF,saliva and RBCs in PD as compared to non-PD patients, supporting that increased α-synuclein oligomer in plasma and CSF as potential diagnostic biomarker for PD5, 6, 7, 22.